Hydroxyurea promotes brain development in children with sickle cell anemia
Sickle cell anemia (SCA) is associated with chronic anemia and cerebrovascular dysfunction, leading to progressive brain atrophy. Hydroxyurea (HU), a disease-modifying therapy, improves hematologic parameters and reduces stroke risk, but its long-term effects on brain development remain unclear. Eve...
Збережено в:
| Автори: | , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2026-09-01
|
| Серія: | Brain Research Bulletin |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S0361923026003217 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|